Actively Recruiting
Treating Major Depression With Yoga Mono-therapy
Led by University of California, San Francisco · Updated on 2025-11-06
180
Participants Needed
1
Research Sites
83 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
The goal of this single-center, single-blind, randomized, controlled, parallel group, interventional trial is to evaluate antidepressant efficacy of yoga monotherapy of 12-weeks duration in 180 adults meeting diagnostic criteria for mild-to-moderate major depression at the Zuckerberg San Francisco General Hospital. Researchers will compare the yoga interventions to an education control intervention on holistic healthcare.
CONDITIONS
Official Title
Treating Major Depression With Yoga Mono-therapy
Who Can Participate
Eligibility Criteria
You may qualify if you...
- 18 years of age or older
- Able to give voluntary, informed consent
- English-speaking
- Diagnosis of clinical depression
You will not qualify if you...
- Current use of antidepressant medication
- Current engagement in psychotherapy
- Current pregnancy
- Significant medical issues interfering with yoga practice
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Zuckerberg San Francisco General Hospital
San Francisco, California, United States, 94110
Actively Recruiting
Research Team
S
Sudha Prathikanti, MD
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
SINGLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here